Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
12.96
-0.09 (-0.65%)
Nov 21, 2024, 11:19 AM EST - Market open
Rocket Pharmaceuticals Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for RCKT stock have an average target of 52.4, with a low estimate of 39 and a high estimate of 65. The average target predicts an increase of 304.48% from the current stock price of 12.96.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for RCKT stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 4 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 4 | 5 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 8 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $39 | Strong Buy | Maintains | $39 | +201.04% | Nov 19, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $46 → $44 | Buy | Maintains | $46 → $44 | +239.64% | Nov 19, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +401.74% | Nov 19, 2024 |
| Needham | Needham | Strong Buy Reiterates $52 | Strong Buy | Reiterates | $52 | +301.39% | Nov 19, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $62 | Strong Buy | Maintains | $62 | +378.58% | Nov 18, 2024 |
Financial Forecast
Revenue This Year
12.54M
Revenue Next Year
64.07M
from 12.54M
Increased by 411.05%
EPS This Year
-2.89
from -2.92
EPS Next Year
-2.64
from -2.89
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 105.4M | 123.9M | 562.9M | ||
| Avg | 12.5M | 64.1M | 254.6M | ||
| Low | n/a | 4.9M | 24.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 888.0% | 778.7% | ||
| Avg | - | 411.0% | 297.4% | ||
| Low | - | -60.9% | -61.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.67 | -1.59 | 0.93 | ||
| Avg | -2.89 | -2.64 | -1.65 | ||
| Low | -3.06 | -3.11 | -2.88 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.